Bellerophon Therapeutics, Inc.

BLPHNASDAQHealthcare

$0.01

$-0.01(-36.84%)

Market Cap$146791

P/E Ratio—

52W High$0.1

52W Low$0.01

Avg Volume13K

Open$0.01

Beta0.70

Insider Trades Ownership Employees

Bellerophon Therapeutics, Inc.（BLPH）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · BLPH · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Bellerophon Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

BLPH 季度内部人买卖趋势

BLPH 内幕交易卖出 · BLPH 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

1.3M651K0

2021 Q1

2021 Q2

2021 Q3

2021 Q4

2022 Q1

2022 Q4

2023 Q1

2023 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

近期内幕交易记录

BLPH 高管卖出股份 · BLPH 董事内幕交易 · SEC Form 4申报

显示最近 37 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Oct 13, 2023	Puissance Capital Management LP 10 percent owner	Sale	1,076,841	$0.10	$112K	0	Form 4
Jun 7, 2023	Amin Naseem Director	Award	47,578	—	—	291,865	Form 4
Jun 7, 2023	Puissance Life Science Opportunities Fund VI 10 percent owner	Sale	134,421	$0.83	$112K	1,076,841	Form 4
May 18, 2023	Kim Bobae VP Reg. Affairs & Quality	Option	1,022	$7.50	$8K	1,723	Form 4
May 18, 2023	Kim Bobae VP Reg. Affairs & Quality	Sale	9,455	$10.00	$95K	1,723	Form 4
May 18, 2023	Kim Bobae VP Reg. Affairs & Quality	Option	266	$7.35	$2K	1,723	Form 4
May 18, 2023	Puissance Life Science Opportunities Fund VI 10 percent owner	Sale	560,000	$9.46	$5.30M⚡	1,211,262	Form 4
Feb 10, 2023	Amin Naseem Director	Award	84,000	—	—	244,287	Form 4
Dec 9, 2022	Dekker Martin Director	Other	7,834	$0.93	$7K	17,666	Form 4
Dec 9, 2022	Shah Parag Suresh Director	Other	7,834	$0.93	$7K	17,666	Form 4
Dec 9, 2022	Laccona Nicholas Director	Other	5,530	$0.93	$5K	12,470	Form 4
Dec 9, 2022	Fernandes Peter Director	Other	9,985	$0.93	$9K	22,515	Form 4
Dec 31, 2021	Amin Naseem Director	Award	39,032	—	—	160,287	Form 4
Jun 7, 2021	Puissance Life Science Opportunities Fund VI 10 percent owner	Award	8,189	$4.00	$33K	1,771,262	Form 4
Apr 26, 2021	Puissance Life Science Opportunities Fund VI 10 percent owner	Award	609,231	$4.00	$2.44M⚡	1,763,077	Form 4
Mar 31, 2021	Peacock Jonathan M Director	Award	15,308	—	—	157,033	Form 4
Mar 18, 2021	New Mountain Investments II, LLC 10 percent owner	Sale	400,000	$5.48	$2.19M⚡	609,231	Form 4
Sep 10, 2020	FARES Wassim Chief Medical Officer	Purchase	4,000	$10.18	$41K	4,000	Form 4
Jun 8, 2020	Wang Theodore T Director	Purchase	2,600	$12.87	$33K	60,913	Form 4
Jun 5, 2020	Wang Theodore T Director	Purchase	4,986	$12.72	$63K	58,313	Form 4
May 21, 2020	Puissance Life Science Opportunities Fund VI 10 percent owner	Award	1,153,846	$13.00	$15.00M⚡	1,153,846	Form 4
Apr 17, 2020	Puissance Cross-Border Opportunities III LLC 10 percent owner	Other	553,250	—	—	0	Form 4
Jan 23, 2020	Peacock Jonathan M Director	Award	350,000	—	—	2,225,920	Form 4
Nov 25, 2019	Wang Theodore T Director	Purchase	7,193	$0.39	$3K	592,922	Form 4
Nov 22, 2019	Wang Theodore T Director	Purchase	1,050	$0.37	$394	585,729	Form 4

Puissance Capital Management LP

10 percent owner

Sale

日期

Oct 13

股数

1,076,841

均价

$0.10

总金额

$112K

View Form 4 on SEC.gov

Amin Naseem

Director

Award

日期

Jun 7

股数

47,578

均价

—

总金额

—

View Form 4 on SEC.gov

Puissance Life Science Opportunities Fund VI

10 percent owner

Sale

日期

Jun 7

股数

134,421

均价

$0.83

总金额

$112K

View Form 4 on SEC.gov

Kim Bobae

VP Reg. Affairs & Quality

Option

日期

May 18

股数

1,022

均价

$7.50

总金额

$8K

View Form 4 on SEC.gov

Kim Bobae

VP Reg. Affairs & Quality

Sale

日期

May 18

股数

9,455

均价

$10.00

总金额

$95K

View Form 4 on SEC.gov

Kim Bobae

VP Reg. Affairs & Quality

Option

日期

May 18

股数

266

均价

$7.35

总金额

$2K

View Form 4 on SEC.gov

Puissance Life Science Opportunities Fund VI

10 percent owner

Sale

日期

May 18

股数

560,000

均价

$9.46

总金额

$5.30M ⚡

View Form 4 on SEC.gov

Amin Naseem

Director

Award

日期

Feb 10

股数

84,000

均价

—

总金额

—

View Form 4 on SEC.gov

Dekker Martin

Director

Other

日期

Dec 9

股数

7,834

均价

$0.93

总金额

$7K

View Form 4 on SEC.gov

Shah Parag Suresh

Director

Other

日期

Dec 9

股数

7,834

均价

$0.93

总金额

$7K

View Form 4 on SEC.gov

Laccona Nicholas

Director

Other

日期

Dec 9

股数

5,530

均价

$0.93

总金额

$5K

View Form 4 on SEC.gov

Fernandes Peter

Director

Other

日期

Dec 9

股数

9,985

均价

$0.93

总金额

$9K

View Form 4 on SEC.gov

Amin Naseem

Director

Award

日期

Dec 31

股数

39,032

均价

—

总金额

—

View Form 4 on SEC.gov

Puissance Life Science Opportunities Fund VI

10 percent owner

Award

日期

Jun 7

股数

8,189

均价

$4.00

总金额

$33K

View Form 4 on SEC.gov

Puissance Life Science Opportunities Fund VI

10 percent owner

Award

日期

Apr 26

股数

609,231

均价

$4.00

总金额

$2.44M ⚡

View Form 4 on SEC.gov

Peacock Jonathan M

Director

Award

日期

Mar 31

股数

15,308

均价

—

总金额

—

View Form 4 on SEC.gov

New Mountain Investments II, LLC

10 percent owner

Sale

日期

Mar 18

股数

400,000

均价

$5.48

总金额

$2.19M ⚡

View Form 4 on SEC.gov

FARES Wassim

Chief Medical Officer

Purchase

日期

Sep 10

股数

4,000

均价

$10.18

总金额

$41K

View Form 4 on SEC.gov

Wang Theodore T

Director

Purchase

日期

Jun 8

股数

2,600

均价

$12.87

总金额

$33K

View Form 4 on SEC.gov

Wang Theodore T

Director

Purchase

日期

Jun 5

股数

4,986

均价

$12.72

总金额

$63K

View Form 4 on SEC.gov

Puissance Life Science Opportunities Fund VI

10 percent owner

Award

日期

May 21

股数

1,153,846

均价

$13.00

总金额

$15.00M ⚡

View Form 4 on SEC.gov

Puissance Cross-Border Opportunities III LLC

10 percent owner

Other

日期

Apr 17

股数

553,250

均价

—

总金额

—

View Form 4 on SEC.gov

Peacock Jonathan M

Director

Award

日期

Jan 23

股数

350,000

均价

—

总金额

—

View Form 4 on SEC.gov

Wang Theodore T

Director

Purchase

日期

Nov 25

股数

7,193

均价

$0.39

总金额

$3K

View Form 4 on SEC.gov

Wang Theodore T

Director

Purchase

日期

Nov 22

股数

1,050

均价

$0.37

总金额

$394

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 2

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 BLPH 内幕交易

BLPH 内幕交易

Bellerophon Therapeutics, Inc.（BLPH）内幕交易数据来源于公司内部人（包括BLPH）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。BLPH内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Bellerophon Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

BLPH 内幕交易 · 5个问题

Bellerophon Therapeutics, Inc.（BLPH）的内部人包括高管和董事，如BLPH等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

BLPH 董事内幕交易BLPH 内部人名单Bellerophon Therapeutics, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026